Lateralized learning and memory effects of angiotensin II microinjected into the rat CA1 hippocampal area

Peptides

Volumn 21, Issue 3, 2000, Pages 407-411

  Belcheva, Iren ^a   Ternianov, Alexandar ^a   Georgiev, Vasil ^a  

^a INSTITUTE OF PHYSIOLOGY   (Bulgaria)

Author keywords

Angiotensin II; Asymmetry; Hippocampus; Learning and memory; Rat

Indexed keywords

ANGIOTENSIN;

ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; COGNITION; CONTROLLED STUDY; HIPPOCAMPUS; LEARNING; MALE; MEMORY; MICROINJECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANGIOTENSIN II; ANIMALS; AVOIDANCE LEARNING; FUNCTIONAL LATERALITY; HIPPOCAMPUS; MALE; MEMORY; MICROINJECTIONS; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT (PSYCHOLOGY);

ANIMALIA; HIPPOCAMPUS HIPPOCAMPUS;

EID: 0034002277     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(00)00163-7     Document Type: Article

References (48)

1. Albrecht D., Broser M., Kruger H. Excitatory action of angiotensin II and IV on hippocampal neuronal activity in urethane anaesthetised rats. Regul Pept. 70:1997;105-109.
2. Baranowska D., Braszko J.J., Wisniewski K. Effect of angiotensin II and vasopressin on acquisitions and extinction of conditioned avoidance in rats. Psychopharmacology (Berlin). 81:1983;247-251.
3. Belcheva I.P., Bryer J.B., Starkstein S.E., Honig M., Moran T.M., Robinson R.G. Hemispheric asymmetry in behavioral response to D-1 and D-2 receptor agonists in the nucleus accumbens. Brain Res. 533:1990;286-291.
4. 1A receptor agonist 8-OH-DPAT. Brain Res. 640:1994;223-228.
5. Belcheva I., Belcheva S., Petkov V.V., Hadjiivanova C., Petkov V.D. Behavioral responses to the 5-HT1A receptor antagonist NAN190 injected into rat CA1 hippocampal area. Gen Pharmacol. 3:1997;435-441.
6. Belcheva I., Georgiev V., Chobanova M., Hadjiivanova C. Behavioral effects of angiotensin II microinjected into CA1 hippocampal area. Neuropeptides. 31:1997;60-64.
7. Belcheva I., Chobanova M., Georgiev V. Differential behavioral effects of angiotensin II microinjected unilaterally into the CA1 hippocampal area. Regul Pept. 74:1998;67-71.
8. Black R.S., Robinson R.G. Intracortical 5,7-dihydroxytryptamine depletes brain serotonin concentrations without affecting spontaneous activity. Pharmacol Biochem Behav. 22:1985;327-331.
9. Braszko J.J., Wisniewski K., Kupriszewski G., Witczuk B. Psychotropic effects of angiotensin II and III in rats locomotor and exploratory vs. cognitive behavior. Behav Brain Res. 25:1987;195-203.
10. Braszko J.J., Wisniewski K. Effect of Angiotensin II and saralasin on motor activity and the passive avoidance behavior of rats. Peptides. 9:1988;475-479.
11. Braszko J.J., Wlasienko J., Kupryszewski G., Witczuk B., Wisniewski K. Behavioral effects of angiotensin II and angiotensin II-(4-8)-pentapeptide in rats. Physiol Behav. 44:1988;327-332.
12. Bunnemann B., Fuxe K., Ganten D. The renin-angiotensin system in the brain an update 1993. Regul Pept. 46:1993;487-509.
13. Denenberg V.H., Garbanati J., Sherman G., Yutzey D.A., Kaplan R. Infantile stimulation induces brain lateralization in rats. Science. 210:1978;1150-1152.
14. Dewberry RG, Lipsey JR, Saad K, Moran TH. Lateralized response to cortical injury in the rats: interhemispheric interaction. Behav Neurosci 1986;100:4:556-62.
15. Diamond M.C., Johnson R.E., Ingham C.A. Morphological changes in the young, adult and aging rat cerebral cortex, hippocampus and diencephalon. Behav Biol. 14:1975;163-164.
16. Ferguson A.V., Washburn D.L.S. Angiotensin II a peptidergic neurotransmitter in central autonomic pathways. Prog Neurobiol. 54:1998;169-192.
17. Georgiev V. Involvement of transmitter mechanisms in the behavioral effects of angiotensin II. Pol J Pharmacol Pharm. 42:1990;553-562.
18. Georgiev V. Angiotensin and brain excitability neuroprotection on seizure susceptibility. Matsoukas J., Mavromoustakos T. Bioactive peptides in drug discovery and design medical aspects. 1999;51-59 IOS Press, Amsterdam.
19. Georgiev V., Yonkov D., Kambourova T. Interactions between angiotensin II and baclophen in shuttle box and passive avoidance performance. Neuropeptides. 12:1988;155-158.
20. Georgiev V, Getova D, Opitz M. Mechanisms of the angiotensin II effects on the exploratory behavior of rats in open field. III. Modulatory role of GABA. Meth Find Exp Clin Pharmacol 1991;13:1-2,5-9.
21. Izquierdo I. Behavioral drug actions and brain lateralization. Trends Pharmacol Sci. 9:1989;344-345.
22. Kambourova T, Georgiev V, Telegdy G. Angiotensin II delays the extinction of the active avoidance in rats. The role of transmitter receptors. Regul Pept, in press.
23. Kolb B., Sutherland R.J., Nonneman A.J., Whishaw I.Q. Asymmetry with cerebral hemisphere of the rat, mouse, rabbit and cat the right hemisphere is larger. Exp Neurol. 78:1982;348-359.
24. Kubos K.L., Moran T.H., Robinson R.G. Differential and asymmetrical behavioral effects of electrolytic or 6-hydroxydopamine lesions in the nucleus accumbens. Brain Res. 401:1987;147-151.
25. Moeller I., Chai S.Y., Oldfield B.J., McKinley M.J., Casley D., Mendelsohn F.A.O. Localisation of angiotensin IV binding sites to motor and sensory neurones in the sheep spinal cord and hindbrain. Brain Res. 701:1995;301-306.
26. Mosiman R., Imboden H., Felix D. The neuronal role of angiotensin II in thirst, sodium appetite, cognition, and memory. Biol Rev. 71:1996;545-559.
27. Pearlson G.D., Robinson R.G. Suction lesions of the frontal cerebral cortex in the rat induce asymmetrical behavioral and catecholaminergic responses. Brain Res. 213:1981;233-242.
28. Robinson RG. Lateralized Behavioral and Neurochemical Consequences of Unilateral Brain Injury in Rats. Cerebral Lateralization in Nonhuman Species. New York: Academic Press Inc, 1985. pp. 135-56.
29. Rosen G.D., Finklestein S., Stoll A.L., Yutzey D., Denenbery V.H. Neurochemical asymmetries in the albino rat's cortex, striatum and nucleus accumbens. Life Sci. 34:1984;1143-1148.
30. Rowe B.P., Grove K.S., Saylor D.S., Speth R.C. Discrimination of angiotensin II receptor subtype distribution in the rat brain using non-peptidic receptor antagonists. Regul Pept. 33:1991;45-53.
31. Storm-Mathisen J., Zimmer J., Ottersen O.P. Understanding the brain through the hippocampus. Prog Brain Res. 83:1990;1-128.
32. Swanson L.W. Brain Maps Structure of the Rat Brain. 1992;Elsevier, New York.
33. Tsutsumi K., Saavedra J.M. Characterization and development of angiotensin II receptor subtypes (AT1 and AT2) in rat brain. Am J Physiol. 261:1991;R209-R216.
34. Von Bohlen O., Albrecht H.D. Mapping of angiotensin AT1 receptors in the limbic system. Regul Pept. 78:1998;54-56.
35. Wayner M.J., Polan-Curtain J., Armstrong D.L. Dose and time dependency of angiotensin II inhibition of hippocampal long-term potentiation. Peptides. 16:1995;1079-1082.
36. Winnicka M.M., Braszko J.J., Wisniewski K. 6-OHDA lesions to amygdala and hippocampus attenuate memory-enhancing effect of the 3-7 fragment of angiotensin II. Gen Pharmacol. 30:1988;801-805.
37. Winnicka M.M., Braszko J.J., Wisniewski K. Dopaminergic protection to the septum mediates facilitatory effect of angiotensin on recognition memory in rats. Pharmacol Res. 36:1997;387-394.
38. Wisniewski K., Braszko J.J. The significance of central monoamine systems in angiotensin II improvement of learning. Clin Exp Hypertens. 6:1984;2127-2131.
39. Wright J.W., Harding J.W. Regulatory role of brain angiotensin in the control of physiological and behavioral responses. Brain Res Rev. 17:1992;227-262.
40. Wright J.W., Harding J.W. Brain angiotensin receptor subtypes in the control of physiological and behavioral responses. Neurosci Behav Rev. 18:1994;21-53.
41. Wright J.W., Harding J.W. Brain angiotensin receptor subtypes AT1, AT2, and AT4 and their functions. Regul Pept. 59:1995;269-295.
42. Wright J.W., Harding J.W. Important roles for angiotensin III and IV in the brain renin-angiotensin system. Brain Res Rev. 25:1997;96-124.
43. Wright J.W., Miller-Wing A.V., Shaffer M.J., Higginson C., Wriht D.E., Hanesworth J.M., Harding J.W. Angiotensin II (3-8) (Ang. IV) hippocampal binding potential role in the facilitation of men. Brain Res Bull. 32:1993;497-502.
44. Wright J.W., Krebs L.T., Stobb J.W., Harding J.W. The angiotensin IV system functional implications. Front Neuroendocrin. 16:1995;23-52.
45. Yonkov D., Georgiev V., Opitz M. Participation of angiotensin II in learning and memory II. Interactions of angiotensin II with dopaminergic drugs. Meth Find Exp Clin Phamacol. 8:1986;203-206.
46. Yonkov D., Georgiev V., Kambourova T., Opitz M. Participation of angiotensin II in memory III. Interaction of angiotensin II with GABAergic drugs. Meth Find Exp Clin Phamacol. 9:1987;205-208.
47. Yonkov D., Georgiev V., Kambourova T. Further evidence for the GABAergic influence on memory. Interaction of GABAergic transmission with angiotensin II on memory processes. Meth Find Exp Clin Phamacol. 11:1989;603-606.
48. Yonkov D., Georgiev V. Cholinergic influence on memory facilitation induced by angiotensin II in rats. Neuropeptides. 16:1990;157-163.